Analysts expect Intuitive Surgical, Inc. (NASDAQ:ISRG) to post earnings of $2.25 per share for the current fiscal quarter, according to Zacks Investment Research. Six analysts have issued estimates for Intuitive Surgical’s earnings, with estimates ranging from $2.18 to $2.29. Intuitive Surgical posted earnings per share of $2.03 during the same quarter last year, which indicates a positive year over year growth rate of 10.8%. The firm is scheduled to announce its next quarterly earnings report on Tuesday, January 23rd.
According to Zacks, analysts expect that Intuitive Surgical will report full-year earnings of $8.72 per share for the current fiscal year, with EPS estimates ranging from $8.70 to $8.75. For the next fiscal year, analysts forecast that the business will post earnings of $9.20 per share, with EPS estimates ranging from $8.88 to $9.51. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research analysts that cover Intuitive Surgical.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 19th. The medical equipment provider reported $2.77 EPS for the quarter, beating the consensus estimate of $1.99 by $0.78. The firm had revenue of $806.10 million during the quarter, compared to the consensus estimate of $753.25 million. Intuitive Surgical had a net margin of 30.16% and a return on equity of 18.20%. The company’s quarterly revenue was up 18.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.06 earnings per share.
Intuitive Surgical (NASDAQ ISRG) opened at $368.09 on Thursday. The company has a market cap of $40,691.28, a PE ratio of 47.56, a PEG ratio of 5.04 and a beta of 0.48. Intuitive Surgical has a one year low of $208.24 and a one year high of $405.05.
In other Intuitive Surgical news, SVP Curet Myriam sold 262 shares of the company’s stock in a transaction dated Tuesday, October 24th. The shares were sold at an average price of $373.00, for a total value of $97,726.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP Jamie Samath sold 1,564 shares of the company’s stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $371.19, for a total transaction of $580,541.16. The disclosure for this sale can be found here. In the last 90 days, insiders sold 55,944 shares of company stock worth $21,432,971. Corporate insiders own 2.20% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the business. Edgewood Management LLC lifted its position in Intuitive Surgical by 200.7% during the third quarter. Edgewood Management LLC now owns 2,898,113 shares of the medical equipment provider’s stock valued at $1,010,359,000 after purchasing an additional 1,934,382 shares during the period. Koch Industries Inc. lifted its position in Intuitive Surgical by 202,917.0% during the second quarter. Koch Industries Inc. now owns 1,388,636 shares of the medical equipment provider’s stock valued at $1,387,000 after purchasing an additional 1,387,952 shares during the period. FMR LLC lifted its position in Intuitive Surgical by 19.6% during the second quarter. FMR LLC now owns 2,724,964 shares of the medical equipment provider’s stock valued at $2,548,849,000 after purchasing an additional 447,397 shares during the period. Janus Henderson Group PLC lifted its position in Intuitive Surgical by 7,931.4% during the second quarter. Janus Henderson Group PLC now owns 412,170 shares of the medical equipment provider’s stock valued at $385,532,000 after purchasing an additional 407,038 shares during the period. Finally, Renaissance Technologies LLC lifted its position in Intuitive Surgical by 57.5% during the second quarter. Renaissance Technologies LLC now owns 307,100 shares of the medical equipment provider’s stock valued at $287,252,000 after purchasing an additional 112,130 shares during the period. Institutional investors and hedge funds own 32.80% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.